CARISSA DAVIS: Open Payments
NPI 1639625551 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,551 in 76 payments from 20 companies in 2025. Trend: 2023 $1,468 · 2024 $1,421 · 2025 $1,551
Food & beverage: $1,551
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 13 | $236 |
| AstraZeneca Pharmaceuticals LP | 14 | $225 |
| PFIZER INC. | 8 | $174 |
| Amgen Inc. | 10 | $151 |
| UCB, Inc. | 1 | $124 |
| Novo Nordisk Inc | 4 | $94 |
| GlaxoSmithKline, LLC. | 4 | $82 |
| SANOFI-AVENTIS U.S. LLC | 3 | $79 |
| SANOFI PASTEUR INC. | 2 | $67 |
| Abbott Laboratories | 3 | $61 |
Products named: MOUNJARO, AIRSUPRA, Bimzelx, OTEZLA, JARDIANCE, TZIELD, PREVNAR 20, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE.
Industry payments across TX — which companies pay providers there.
